AIMD
Price
$3.49
Change
-$0.14 (-3.86%)
Updated
Sep 5 closing price
Capitalization
16.26M
MBOT
Price
$3.66
Change
+$0.29 (+8.61%)
Updated
Sep 5 closing price
Capitalization
177.56M
61 days until earnings call
Interact to see
Advertisement

AIMD vs MBOT

Header iconAIMD vs MBOT Comparison
Open Charts AIMD vs MBOTBanner chart's image
AINOS
Price$3.49
Change-$0.14 (-3.86%)
Volume$72.14K
Capitalization16.26M
Microbot Medical
Price$3.66
Change+$0.29 (+8.61%)
Volume$2.35M
Capitalization177.56M
AIMD vs MBOT Comparison Chart in %
Loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIMD vs. MBOT commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a Hold and MBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (AIMD: $3.49 vs. MBOT: $3.66)
Brand notoriety: AIMD and MBOT are both not notable
AIMD represents the Medical/Nursing Services, while MBOT is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AIMD: 2% vs. MBOT: 99%
Market capitalization -- AIMD: $16.26M vs. MBOT: $177.56M
AIMD [@Medical/Nursing Services] is valued at $16.26M. MBOT’s [@Pharmaceuticals: Other] market capitalization is $177.56M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIMD’s FA Score shows that 0 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • AIMD’s FA Score: 0 green, 5 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than AIMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIMD’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 5 bullish TA indicator(s).

  • AIMD’s TA Score: 4 bullish, 5 bearish.
  • MBOT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MBOT is a better buy in the short-term than AIMD.

Price Growth

AIMD (@Medical/Nursing Services) experienced а -8.64% price change this week, while MBOT (@Pharmaceuticals: Other) price change was -3.94% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

MBOT is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBOT($178M) has a higher market cap than AIMD($16.3M). MBOT YTD gains are higher at: 226.786 vs. AIMD (53.070). AIMD has higher annual earnings (EBITDA): -10.14M vs. MBOT (-13.4M). MBOT has more cash in the bank: 32.7M vs. AIMD (1.22M). MBOT has less debt than AIMD: MBOT (149K) vs AIMD (11M). AIMD has higher revenues than MBOT: AIMD (111K) vs MBOT (0).
AIMDMBOTAIMD / MBOT
Capitalization16.3M178M9%
EBITDA-10.14M-13.4M76%
Gain YTD53.070226.78623%
P/E RatioN/AN/A-
Revenue111K0-
Total Cash1.22M32.7M4%
Total Debt11M149K7,383%
FUNDAMENTALS RATINGS
AIMD vs MBOT: Fundamental Ratings
AIMD
MBOT
OUTLOOK RATING
1..100
5084
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
4535
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBOT's Valuation (57) in the Biotechnology industry is in the same range as AIMD (68) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.

MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AIMD (100) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.

MBOT's SMR Rating (98) in the Biotechnology industry is in the same range as AIMD (99) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.

MBOT's Price Growth Rating (35) in the Biotechnology industry is in the same range as AIMD (45) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.

MBOT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AIMD (100) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMDMBOT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 14 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YZCFF0.07N/A
N/A
Sinopec Yizheng Chem Fibre Co Ltd
FNTTF0.26N/A
N/A
XR IMMERSIVE TECH INC.
BCOMF5.93N/A
N/A
B Communications Ltd
AKTAF1.46N/A
N/A
Akita Drilling Ltd.
HMRZF14.15N/A
N/A
Hennes & Mauritz AB

AIMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, AIMD has been loosely correlated with AHICF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AIMD jumps, then AHICF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIMD
1D Price
Change %
AIMD100%
-3.86%
AHICF - AIMD
46%
Loosely correlated
N/A
BNR - AIMD
41%
Loosely correlated
-1.78%
SINT - AIMD
40%
Loosely correlated
+25.80%
APDN - AIMD
38%
Loosely correlated
-17.01%
CODX - AIMD
38%
Loosely correlated
+0.29%
More

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with POAI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then POAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+8.61%
POAI - MBOT
42%
Loosely correlated
-1.13%
BNGO - MBOT
34%
Loosely correlated
+9.62%
RCEL - MBOT
34%
Loosely correlated
-0.70%
AIMD - MBOT
32%
Poorly correlated
-3.86%
NNOX - MBOT
30%
Poorly correlated
-0.81%
More